Press Releases

01.05.2021
Iveric Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
12.17.2020
Iveric Bio to Present at the 39th Annual J.P. Morgan Healthcare Conference
12.04.2020
Iveric Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
11.02.2020
Iveric Bio Reports Third Quarter 2020 Operational Highlights and Financial Results
10.29.2020
Iveric Bio to Participate in Upcoming Virtual Investor / Industry Conferences
10.26.2020
Iveric Bio to Report Third Quarter 2020 Financial Results and Host Conference Call on Monday, November 2, 2020
10.02.2020
Iveric Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
09.03.2020
Iveric Bio to Participate in Upcoming September Investor / Industry Conferences
09.02.2020
Iveric Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
09.01.2020
Iveric Bio Announces Publication of GATHER1 Phase 3 Clinical Trial Results for Zimura® in Geographic Atrophy Secondary to Age-related Macular Degeneration, in Ophthalmology®, the Journal of the American Academy of Ophthalmology